Literature DB >> 19241439

Risk of cataract among idiopathic thrombocytopenic purpura patients in the UK general practice research database.

Maurille A Feudjo-Tepie1, Susan A Hall, John Logie, Noah J Robinson.   

Abstract

PURPOSE: To estimate the incidence of cataracts in an adult idiopathic thrombocytopenic purpura (ITP) and in a comparable non-ITP population, stratified by age, gender and medication use in order to determine whether the risk of cataracts is greater in ITP patients.
METHODS: Retrospective cohort of 745 newly diagnosed ITP patients and 3725 non-ITP subjects who were 18 years of age or older. The study population included patients registered on the General Practice Research Database (GPRD) during the period 1992-2005. ITP patients, identified using Read/Oxmis codes, were matched to five non-ITP patients. The exposure of interest was oral systemic steroid use and the primary outcome was cataracts.
RESULTS: The overall incidence rate of cataracts in males was 11.8 per 1000 PY (95%CI: 6.3-20.2) and in females 9.0 per 1000 PY (95%CI: 5.2-14.4). In the non-ITP population these rates were 14.0 per 1000 PY (95%CI: 11.0-17.4) and 8.1 per 1000 PY (95%CI: 6.4-10.1), respectively. In the ITP population, users of oral steroids (OS) had a cataract incidence rate of 14.0 per 1000 PY (95%CI: 8.7-21.4) and non-users 6.0 per 1000 PY (95%CI: 2.8-11.4). In the non-ITP population, these rates were 16.9 per 1000 PY (95%CI: 11.9-23.3) and 9.2 per 1000 PY (95%CI: 7.6-11.0), respectively. OS were associated with an increased risk for cataracts.
CONCLUSIONS: The rates of cataract in an adult ITP population are comparable to that in a non-ITP population.

Entities:  

Mesh:

Year:  2009        PMID: 19241439     DOI: 10.1002/pds.1723

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  3 in total

1.  Comorbidities in patients with persistent or chronic immune thrombocytopenia.

Authors:  Cheryl Enger; Dimitri Bennett; Ulla Forssen; Patrick F Fogarty; Andrew T McAfee
Journal:  Int J Hematol       Date:  2010-07-24       Impact factor: 2.490

2.  Pulmonary Thromboembolism in Immune Thrombocytopenia: A Report of Five Cases and a Review of the Literature.

Authors:  Yong Tan; Min Yan; Zhen Cheng; Xiangtao Pan
Journal:  Int J Gen Med       Date:  2021-08-13

3.  Description of an incidence-based model for Assessing comorbidity patterns in disease natural history.

Authors:  Victor A Kiri
Journal:  BMJ Open       Date:  2016-07-25       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.